News Releases

Date Title
09/05/2018 Summary ToggleEnanta Pharmaceuticals to Present New Data on its RSV Inhibitor EDP-938 at the 11th International Respiratory Syncytial Virus Symposium
08/27/2018 Summary ToggleEnanta Pharmaceuticals to Present at Two Upcoming Investor Conferences
08/07/2018 Summary ToggleEnanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2018
07/16/2018 Summary ToggleEnanta Pharmaceuticals to Host Conference Call on August 7 at 4:30 p.m. ET to Discuss Financial Results for its Fiscal Third Quarter Ended June 30, 2018
06/12/2018 Summary ToggleEnanta Pharmaceuticals Recognizes the 1st International NASH Day
06/01/2018 Summary ToggleEnanta Pharmaceuticals to Present at the NASDAQ 38th Investor Conference Presentation to be Webcast on June 12 at 9:30 A.M. GMT
05/08/2018 Summary ToggleEnanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2018
04/24/2018 Summary ToggleEnanta Pharmaceuticals to Host Conference Call on May 8 at 4:30 p.m. ET to Discuss Financial Results for its Fiscal Second Quarter Ended March 31, 2018
04/12/2018 Summary ToggleEnanta to Present New Data for Core Inhibitor for Hepatitis B Virus and FXR Agonist EDP-305 for NASH at The International Liver Congress™ 2018
03/28/2018 Summary ToggleEnanta Pharmaceuticals Announces Data Presentations at The International Liver Congress™ 2018